Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8

NCT02507167 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Hormones

Interventions

DIETARY_SUPPLEMENT: mixed meal
DRUG: Rifampin

Sponsor

University Medicine Greifswald